Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell Lymphoma
Clinical trial NCT03704298 · TERMINATED
Trial details
- NCT number
- NCT03704298
- Sponsor
- Kite, A Gilead Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-20
- Primary completion
- 2021-05-07
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.